Company / Book Value per Share
GT Biopharma, Inc. Book Value per Share History
FY2011-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
-$4.704
FY2020
5-year range
-$25.764 / $2.4K
FY2016-FY2020
Trend
-100.2%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has fluctuated over the past 8 years, ranging from -$25.764 in FY2016 to $2,415.024 in FY2017.
Based on SEC 10-K filings.
-$4.704 in FY2020.
Improved from -$25.764 to -$4.704 over the past 4 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, book value per share decreased 100.2% year-over-year.
- Peak book value per share was recorded in FY2017.
- Lowest book value per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$4.704 | -100.2% |
| FY2017 | $2.4K | +9473.6% |
| FY2016 | -$25.764 | -106.2% |
| FY2015 | -$12.496 | -24114.2% |
| FY2014 | -$0.052 | -307.9% |
| FY2013 | -$0.013 | +46.2% |
| FY2012 | -$0.024 | +31.0% |
| FY2011 | -$0.034 | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026